Kardigan, Inc. Common Stock Cash Flow Conversion Efficiency
Kardigan, Inc. Common Stock cash flow conversion efficiency. Based on the latest financial reports, Kardigan, Inc. Common Stock (KARD) has a cash flow conversion efficiency ratio of -0.082x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-50.55 Million) by net assets ($615.52 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Kardigan, Inc. Common Stock (2024–2025)
Cash flow conversion efficiency of Kardigan, Inc. Common Stock from 2024 to 2025. This chart illustrates how Kardigan, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Kardigan, Inc. Common Stock share price for real-time trading data and today's change.
Kardigan, Inc. Common Stock Cash Flow Conversion Ratio Explained
Kardigan, Inc. Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Kardigan, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kardigan, Inc. Common Stock ranked by their cash flow conversion efficiency. Also see market cap of Kardigan, Inc. Common Stock for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
V-Guard Industries Limited
NSE:VGUARD
|
0.082x |
|
Teladoc Inc
NYSE:TDOC
|
0.071x |
|
Aygaz AS
IS:AYGAZ
|
0.003x |
|
Suzhou Veichi Electric Co. Ltd. A
SHG:688698
|
-0.007x |
|
Adient PLC
NYSE:ADNT
|
0.099x |
|
Anhui Hengyuan Coal Industry and Electricity Power Co Ltd
SHG:600971
|
0.013x |
|
Liquidity Services Inc
NASDAQ:LQDT
|
0.132x |
|
Shanghai Environment Group Co Ltd
SHG:601200
|
0.036x |
Annual Cash Flow Conversion Efficiency for Kardigan, Inc. Common Stock (2024–2025)
The table below shows the annual cash flow conversion efficiency of Kardigan, Inc. Common Stock from 2024 to 2025. Review Kardigan, Inc. Common Stock leverage flexibility ratio to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-250.34 Million | $-151.06 Million | 0.603x | +166.67% |
| 2024-12-31 | $-83.19 Million | $-18.82 Million | 0.226x | -- |
About Kardigan, Inc. Common Stock
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI… Read more